Wang et al. found that RPL7A was one of the most significant survival-predicting differentiation-related genes [glioblastoma (GBM) cell differentiation-related genes (GDRGs)], and low expression of RPL7A was associated with poor overall survival (OS) in GBM patients (30). This evidence concerns the gene RPL7A and glioblastoma.